Posted in | News | New Product

Quantum Leap Forward: Zurich Instruments Unveils the SHF+ Product Line for High-Fidelity Qubit Control

This March, Zurich Instruments launches the newest system for control and readout of superconducting qubits, including a full measurement software framework: the SHFSG+ Signal Generator, SHFQC+ Qubit Controller, and SHFQA+ Quantum Analyzer. Designed to the limits of analog performance, the SHF+ product line unites high-fidelity qubit control and quality performance, and accelerates the development of longer coherence time qubits and scaling up QPUs.

Image Credit: Zurich Instruments

The SHFSG+, SHFQC+, and SHFQA+ improve the signal-to-noise ratio (SNR) by 10 dB, placing them among the highest available on the market. Such a high SNR dramatically reduces thermal qubit excitation and, in turn, maximizes quantum computing algorithm fidelity. A substantially improved phase noise allows for suppressing phase errors in the control of long-lived qubits.

By working closely with many leading quantum computing research groups, we’ve observed that the setup allows for reduction of the phase error limit up to ten times and reaches levels of 10-6 for qubits in the millisecond lifetime range”, 

Dr. Bruno Küng, principal product marketing manager at Zurich Instruments

In addition to a noise-optimized signal chain, the SHF+ products also offer the ability to actively mute the output for measurements on even the most sensitive of qubits.

“The new SHFSG+, SHFQC+ and SHFQA+ are the result of collaborations across the globe to provide the highest quality control electronics to the very people who are making great improvements in qubit quality - gate fidelity, lifetime, coherence - day by day. And we seal it all with the Swiss cross for quality”, says Dr. Mark Kasperczyk, senior product manager at Zurich Instruments.

“Strong connections to research have allowed us to stay on the frontiers of science, as well as to scale our operations in a sustainable way. We thank our R&D teams for developing the SHF+ line, and to institutes such as ETH Zurich and many others for performing validations. This is a step towards more computational quantum power: better and longer quantum circuits, even for a few qubits, and the use of larger chips for more powerful QPUs. The story goes on - towards 4 9s and hundreds of qubits to accelerate the second quantum revolution”, concludes Dr. Sadik Hafizovic, the CEO of Zurich Instruments.

The SHFQC+, SHFSG+ and SHFQA+ will be launched at the meeting of the American Physical Society (APS), 4th – 8th of March, in Minneapolis, USA. Zurich Instruments’ Quantum Technologies team is looking forward to meeting you in-person at Booth 811. Otherwise, simply contact any of our international offices. We speak your language. 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Zurich Instruments. (2024, February 29). Quantum Leap Forward: Zurich Instruments Unveils the SHF+ Product Line for High-Fidelity Qubit Control. AZoM. Retrieved on June 17, 2024 from https://www.azom.com/news.aspx?newsID=62621.

  • MLA

    Zurich Instruments. "Quantum Leap Forward: Zurich Instruments Unveils the SHF+ Product Line for High-Fidelity Qubit Control". AZoM. 17 June 2024. <https://www.azom.com/news.aspx?newsID=62621>.

  • Chicago

    Zurich Instruments. "Quantum Leap Forward: Zurich Instruments Unveils the SHF+ Product Line for High-Fidelity Qubit Control". AZoM. https://www.azom.com/news.aspx?newsID=62621. (accessed June 17, 2024).

  • Harvard

    Zurich Instruments. 2024. Quantum Leap Forward: Zurich Instruments Unveils the SHF+ Product Line for High-Fidelity Qubit Control. AZoM, viewed 17 June 2024, https://www.azom.com/news.aspx?newsID=62621.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.